EdgarLookup
SC 13G

SCHEDULE 13G

Company
Kiniksa Pharmaceuticals International, plc
Filed
July 19, 2018
Accession Number
0000897101-18-000644

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →